Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

NCT00381680 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

275

Enrollment

NETWORK

Sponsor class

Conditions

B-cell Childhood Acute Lymphoblastic Leukemia
L1 Childhood Acute Lymphoblastic Leukemia
L2 Childhood Acute Lymphoblastic Leukemia
Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia

Interventions

DRUG: vincristine sulfate
DRUG: prednisone
DRUG: doxorubicin hydrochloride
DRUG: pegaspargase
DRUG: cytarabine
DRUG: methotrexate
DRUG: dexamethasone
DRUG: etoposide
DRUG: cyclophosphamide
DRUG: leucovorin calcium
BIOLOGICAL: filgrastim
DRUG: asparaginase
DRUG: mercaptopurine

Sponsor

Children's Oncology Group

Collaborators

[object Object]